GlassScriptPrepare for your visit
Brian C Melley
Podiatrist · Florala, AL · NPI 1750449526
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$639.56
in general payments reported to CMS, 2019-2025 · $231 in 2025
The $231 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Who reported paying
General payments only, top 6 by amount.
- Organogenesis INC. $183.16
- Kerecis Limited $152.73
- Tactile Systems Technology INC $98.08
- Ibsa Pharma INC. $44.06
- Nevro Corp. $43.49
- Averitas Pharma INC. $39.91
Drugs and devices associated with these payments
Kerecis Omega3 Surgiclose Kerecis Omega3 Marigen Kerecis Omega3 Graftguide Tirosint Via Matrix Puraply Wound Matrix Cygnus Dual Licart Qutenza Seglentis Senza
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Brian Melley listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/954091/brian-c-melley